S10 Ep9: FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL

from OncLive® On Air · host OncLive® On Air

Dr Davids discusses the FDA approval of pirtobrutinib for patients with previously treated CLL/SLL; key efficacy and safety data from the BRUIN trial; and guidelines for pirtobrutinib use in clinical practice in the CLL/SLL patient population.

Episode metadata supplied by the publisher feed · Published Jan 25, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

S10 Ep9: FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL

0:00 10:54

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncLive® On Air?

This episode is 10 minutes long.

When was this OncLive® On Air episode published?

This episode was published on January 25, 2024.

Can I download this OncLive® On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!